Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Medplus Health Services Limited (NSE: MEDPLUS), ISIN INE804L01022 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MEDPLUS last traded at ₹614.70 (+1.67%), with a 52-week range of ₹566.00 to ₹1020.35 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 40.19%, FIIs 12.58%, DIIs 31.89%, mutual funds 27.39%.
EquiSense Score (ECS): 73/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.